Escitalopram vs. Fluoxetine

See how Escitalopram and Fluoxetine compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Both escitalopram and fluoxetine are SSRIs for major depressive disorder, but fluoxetine also covers OCD, panic disorder, and bulimia nervosa.

  • Escitalopram uses a simple once-daily dose that reaches its 20 mg target in about a week, while fluoxetine offers dose ranges up to 80 mg or a once-weekly 90 mg option.

  • Fluoxetine's active metabolite lingers in the body for weeks after stopping, while escitalopram clears faster and causes fewer drug interactions.

Escitalopram vs. Fluoxetine Drug Summary

Escitalopram

Escitalopram is a selective serotonin reuptake inhibitor (SSRI) approved to treat major depressive disorder in adults and adolescents 12 and older, as well as generalized anxiety disorder in adults. It is taken as a single daily tablet or oral solution, usually starting at 10 mg and increasing to 20 mg after one week.

Fluoxetine

Fluoxetine is also an SSRI, approved for major depressive disorder, obsessive-compulsive disorder, panic disorder, and bulimia nervosa, and in combination with olanzapine for bipolar depression. It comes as a capsule, tablet, or oral solution, usually starting at 10 mg daily and adjusted based on the condition being treated.

Escitalopram vs. Fluoxetine Side Effects

Escitalopram

Most common
nausea (up to 15%)
insomnia (up to 9%)
ejaculation disorder (up to 9%)
fatigue (up to 8%)

Fluoxetine

Most common
nausea (up to 21%)
insomnia (up to 33%)
headache (up to 21%)
somnolence (up to 13%)

Escitalopram vs. Fluoxetine Dosage

Escitalopram

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily Week 1
Maximum dose 20 mg once daily Week 2 onward
Dose changes 1 increase Every week

Fluoxetine

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily Week 1
Maximum dose 90 mg once weekly If needed
Dose changes 4 increases Every week

Escitalopram vs. Fluoxetine Indications

Escitalopram

Escitalopram is FDA-approved to treat major depressive disorder in adults and adolescents aged 12 to 17, and generalized anxiety disorder in adults. It is not approved for children under 12 or for bipolar depression.

  • Major depressive disorder in adults

  • Major depressive disorder in adolescents 12-17

  • Generalized anxiety disorder in adults

Fluoxetine

Fluoxetine is FDA-approved for major depressive disorder in adults and children as young as 8, obsessive-compulsive disorder in ages 7 and up, panic disorder, and bulimia nervosa in adults. It is also approved in combination with olanzapine for bipolar depression and treatment-resistant depression.

  • Major depressive disorder in adults and children 8-18

  • Obsessive-compulsive disorder in adults and children 7-17

  • Panic disorder in adults

Escitalopram vs. Fluoxetine Pros and Cons

Escitalopram

Escitalopram is generally well tolerated with a straightforward once-daily dosing schedule that reaches its target dose within about a week. It has fewer known drug interactions than fluoxetine because it does not strongly inhibit the liver enzymes that metabolize other medications.

Pros

  • Simple two-step dosing reaches target in about a week

  • Fewer drug interactions from weaker CYP2D6 inhibition

  • Approved for generalized anxiety disorder

  • Low-cost generic tablets and oral solution

Cons

  • Not approved for OCD, panic disorder, or bulimia

  • No once-weekly maintenance dosing option

  • Not approved for children under 12

  • No FDA-approved combination therapy for bipolar depression

Fluoxetine

Fluoxetine covers the widest range of FDA-approved uses among SSRIs, including OCD, panic disorder, and bulimia nervosa, and it can be combined with olanzapine for bipolar depression. Its long half-life allows a once-weekly maintenance option but also means it can linger in the body for weeks after stopping.

Pros

  • Approved for OCD, panic disorder, and bulimia nervosa

  • Once-weekly maintenance dosing option available

  • Approved for children as young as 8 for MDD

  • Decades of use and low-cost generic availability

Cons

  • Stronger CYP2D6 inhibition raises interaction risk

  • Long half-life delays clearance if side effects occur

  • Higher rates of insomnia and gastrointestinal side effects

  • Contraindicated with pimozide and thioridazine

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.